3-86978691-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_016206.4(VGLL3):c.238G>A(p.Glu80Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000233 in 1,461,866 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016206.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGLL3 | NM_016206.4 | c.238G>A | p.Glu80Lys | missense_variant | Exon 2 of 4 | ENST00000398399.7 | NP_057290.2 | |
VGLL3 | NM_001320493.2 | c.238G>A | p.Glu80Lys | missense_variant | Exon 2 of 4 | NP_001307422.1 | ||
VGLL3 | XM_006713138.5 | c.235G>A | p.Glu79Lys | missense_variant | Exon 2 of 4 | XP_006713201.1 | ||
VGLL3 | NM_001320494.2 | c.127-48G>A | intron_variant | Intron 1 of 3 | NP_001307423.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGLL3 | ENST00000398399.7 | c.238G>A | p.Glu80Lys | missense_variant | Exon 2 of 4 | 1 | NM_016206.4 | ENSP00000381436.2 | ||
VGLL3 | ENST00000383698.3 | c.238G>A | p.Glu80Lys | missense_variant | Exon 2 of 4 | 1 | ENSP00000373199.3 | |||
VGLL3 | ENST00000494229.1 | c.85-48G>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000419115.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249290Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135242
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727232
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.238G>A (p.E80K) alteration is located in exon 2 (coding exon 2) of the VGLL3 gene. This alteration results from a G to A substitution at nucleotide position 238, causing the glutamic acid (E) at amino acid position 80 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at